TrialRelacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Trial details
- Registry ID
- NCT06906341
- Phase
- Phase 2
Drug research
Bevacizumab 10 mg/kg
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersNCT06906341 | Corcept Therapeutics | Phase 2 | Recruiting | 2026-08Estimated |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |